157 related articles for article (PubMed ID: 12083459)
21. Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Bellavance E; Luu-The V; Poirier D
J Med Chem; 2009 Dec; 52(23):7488-502. PubMed ID: 19772289
[TBL] [Abstract][Full Text] [Related]
22. Phytoestrogens: recent developments.
Cos P; De Bruyne T; Apers S; Vanden Berghe D; Pieters L; Vlietinck AJ
Planta Med; 2003 Jul; 69(7):589-99. PubMed ID: 12898412
[TBL] [Abstract][Full Text] [Related]
23. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
24. Natural modulators of estrogen biosynthesis and function as chemopreventive agents.
Bhat KP; Pezzuto JM
Arch Pharm Res; 2001 Dec; 24(6):473-84. PubMed ID: 11794520
[TBL] [Abstract][Full Text] [Related]
25. Characterization of hamster NAD+-dependent 3(17)β-hydroxysteroid dehydrogenase belonging to the aldo-keto reductase 1C subfamily.
Endo S; Noda M; Ikari A; Tatematsu K; El-Kabbani O; Hara A; Kitade Y; Matsunaga T
J Biochem; 2015 Nov; 158(5):425-34. PubMed ID: 26002966
[TBL] [Abstract][Full Text] [Related]
26. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
[TBL] [Abstract][Full Text] [Related]
27. Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1.
Brozic P; Smuc T; Gobec S; Rizner TL
Mol Cell Endocrinol; 2006 Oct; 259(1-2):30-42. PubMed ID: 16962702
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.
Kao YC; Zhou C; Sherman M; Laughton CA; Chen S
Environ Health Perspect; 1998 Feb; 106(2):85-92. PubMed ID: 9435150
[TBL] [Abstract][Full Text] [Related]
29. Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities.
Le Bail JC; Pouget C; Fagnere C; Basly JP; Chulia AJ; Habrioux G
Life Sci; 2001 Jan; 68(7):751-61. PubMed ID: 11205867
[TBL] [Abstract][Full Text] [Related]
30. Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells.
Lacey M; Bohday J; Fonseka SM; Ullah AI; Whitehead SA
J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):279-86. PubMed ID: 16023337
[TBL] [Abstract][Full Text] [Related]
31. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
[TBL] [Abstract][Full Text] [Related]
32. Aromatase and 17beta-hydroxysteroid dehydrogenase inhibition by flavonoids.
Le Bail JC; Laroche T; Marre-Fournier F; Habrioux G
Cancer Lett; 1998 Nov; 133(1):101-6. PubMed ID: 9929167
[TBL] [Abstract][Full Text] [Related]
33. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
Zava DT; Duwe G
Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
[TBL] [Abstract][Full Text] [Related]
34. Influence of the dietary flavonoid quercetin on the cardioprotective antioxidant action of oestrogen and phytoestrogens.
Wiseman H; O'Reilly J
Biochem Soc Trans; 1997 Feb; 25(1):108S. PubMed ID: 9057006
[No Abstract] [Full Text] [Related]
35. Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
Fink BE; Gavai AV; Tokarski JS; Goyal B; Misra R; Xiao HY; Kimball SD; Han WC; Norris D; Spires TE; You D; Gottardis MM; Lorenzi MV; Vite GD
Bioorg Med Chem Lett; 2006 Mar; 16(6):1532-6. PubMed ID: 16386902
[TBL] [Abstract][Full Text] [Related]
36. The derivation of a potential transition state for the reduction reaction catalysed by 17beta-hydroxysteroid dehydrogenase--an approximate representation of its active site for use in drug design and discovery.
Owen CP; Ahmed S
Biochem Biophys Res Commun; 2004 May; 318(1):131-4. PubMed ID: 15110763
[TBL] [Abstract][Full Text] [Related]
37. STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model.
Day JM; Foster PA; Tutill HJ; Schmidlin F; Sharland CM; Hargrave JD; Vicker N; Potter BV; Reed MJ; Purohit A
Endocr Relat Cancer; 2013 Feb; 20(1):53-64. PubMed ID: 23132791
[TBL] [Abstract][Full Text] [Related]
38. Cinnamates and cinnamamides inhibit fungal 17beta-hydroxysteroid dehydrogenase.
Kristan K; Starcević S; Brunskole M; Rizner TL; Gobec S
Mol Cell Endocrinol; 2006 Mar; 248(1-2):239-41. PubMed ID: 16337334
[TBL] [Abstract][Full Text] [Related]
39. Androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase.
Ngatcha BT; Luu-The V; Poirier D
Bioorg Med Chem Lett; 2000 Nov; 10(22):2533-6. PubMed ID: 11086723
[TBL] [Abstract][Full Text] [Related]
40. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K
Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]